Global Gamma
Knife Market, by Indication (Brain Metastasis, Arteriovenous Malformation
(AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), by Anatomy
(Neck and Head), by End-user (Hospitals, Clinics and Ambulatory Surgical
Centers), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) was valued at US$
173.55 million in 2019 and is expected to exhibit a CAGR of 3.2% over
the forecast period (2019-2027).
The rising number of neurological
surgeries is expected to drive the growth of the global gamma knife market over
the forecast period. For instance, according to the Healthcare Cost and
Utilization Project (HCUP) report, in 2014, 17.2 million hospital visits
(ambulatory or inpatient) included invasive and therapeutic surgeries. Over
half of these visits (9.9 million visits) occurred in ambulatory surgery (AS)
settings, and the remaining 7.2 million were inpatient surgeries. Increasing
prevalence of brain tumors is expected to boost global gamma knife market
growth. For instance, according to the Central Brain Tumor Registry of the
United States (CBTRUS) 2018, the incidence of all primary malignant and non-malignant
brain tumors, and other CNS tumors was 23.03 cases per 100,000 for 392,982
tumors in 2018. According to the same source, an estimated 86,970 new cases of
primary malignant and non-malignant brain and other CNS tumors are expected to
be diagnosed in the U.S. in 2019. The global gamma knife market size is
expected to witness significant growth during the forecast period, owing to
increase in regulatory approvals for gamma knife products.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/408
For instance, in June 2015,
Elekta, received 510(k) clearance from the U.S. Food and Drug Administration
(FDA) and CE Marking for Leksell Gamma Knife Icon. Which is the world’s most
precise and sophisticated system for radiosurgery treatment of certain brain
tumors, vascular malformations and functional disorders.
Browse 35 Market Data Tables and
33 Figures spread through 185 Pages and in-depth TOC on "Global Gamma
Knife Market, by Indication (Brain Metastasis, Arteriovenous Malformation
(AVM), Trigeminal Neuralgia, Movement Disorders, Cancer and Others), by Anatomy
(Neck and Head), by End-user (Hospitals, Clinics and Ambulatory Surgical
Centers), and by Region (North America, Latin America, Europe, Asia Pacific,
Middle East, and Africa) - Global Forecast to 2027"
In July 2019, University of
Minnesota launches exclusive gamma knife technology for radiation therapy, is
used to treat brain tumor patients with the latest generation advanced
radiosurgery technology. The radiosurgery works by focusing radiation beams
from different angles to a small target.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/gamma-knife-market-408
Key Takeaways of the Global Gamma
Knife Market:
The global gamma knife market is
expected to exhibit a CAGR of 3.2% over the forecast period (2019–2027) owing
to increasing prevalence of brain tumors and number of neurological surgeries
Among indication type, the brain
metastasis segment is expected to account for a major revenue share by 2027.
Brain metastasis is a type of cancer that can spread to the brain from another
location in the body and is also considered as secondary brain tumor.
Major players operating in the
global gamma knife market include Elekta AB, Varian Medical Systems Inc.,
Huiheng Medical Inc., Cyber Medical Corporation Limited, Masep Infini Global
Inc., ET Medical Group, Nordion Inc., Hokai and GE Healthcare.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/408
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment